To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to compare the safety, tolerability, and pharmacokinetics of QBX258
(sequential administration of a fixed dose of VAK694 and single ascending doses of QAX576) in
patients with well-controlled mild to moderate asthma.